203 related articles for article (PubMed ID: 22044775)
41. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
[TBL] [Abstract][Full Text] [Related]
42. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
43. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
[TBL] [Abstract][Full Text] [Related]
45. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
46. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
[TBL] [Abstract][Full Text] [Related]
47. Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer.
Adelstein DJ; Rice TW; Rybicki LA; Greskovich JF; Ciezki JP; Carroll MA; DeCamp MM
Lung Cancer; 2002 May; 36(2):167-74. PubMed ID: 11955651
[TBL] [Abstract][Full Text] [Related]
48. Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?
Bisof V; Rakusic Z; Despot M
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1553-67. PubMed ID: 24890977
[TBL] [Abstract][Full Text] [Related]
49. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Choi HS; Park do J; Jung KC; Sung MW; Kim KH; Hah JH; Park YJ
Thyroid; 2016 Sep; 26(9):1259-68. PubMed ID: 27412715
[TBL] [Abstract][Full Text] [Related]
50. Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery.
Tennvall J; Tallroth E; el Hassan A; Lundell G; Akerman M; Biörklund A; Blomgren H; Löwhagen T; Wallin G
Acta Oncol; 1990; 29(8):1025-8. PubMed ID: 2278722
[TBL] [Abstract][Full Text] [Related]
51. High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel.
Troch M; Koperek O; Scheuba C; Dieckmann K; Hoffmann M; Niederle B; Raderer M
J Clin Endocrinol Metab; 2010 Sep; 95(9):E54-7. PubMed ID: 20591979
[TBL] [Abstract][Full Text] [Related]
52. Anaplastic giant cell thyroid carcinoma.
Wallin G; Lundell G; Tennvall J
Scand J Surg; 2004; 93(4):272-7. PubMed ID: 15658667
[TBL] [Abstract][Full Text] [Related]
53. Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors.
Ito K; Hanamura T; Murayama K; Okada T; Watanabe T; Harada M; Ito T; Koyama H; Kanai T; Maeno K; Mochizuki Y; Amano J
Head Neck; 2012 Feb; 34(2):230-7. PubMed ID: 21500309
[TBL] [Abstract][Full Text] [Related]
54. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
[TBL] [Abstract][Full Text] [Related]
55. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
Wendler J; Kroiss M; Gast K; Kreissl MC; Allelein S; Lichtenauer U; Blaser R; Spitzweg C; Fassnacht M; Schott M; Führer D; Tiedje V
Eur J Endocrinol; 2016 Dec; 175(6):521-529. PubMed ID: 27926471
[TBL] [Abstract][Full Text] [Related]
56. [Radiation therapy in thyroid cancer].
Sun XS; Guevara N; Fakhry N; Sun SR; Marcy PY; Santini J; Bosset JF; Thariat J
Cancer Radiother; 2013 Jun; 17(3):233-43; quiz 255-6, 258. PubMed ID: 23763764
[TBL] [Abstract][Full Text] [Related]
57. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group.
Tennvall J; Lundell G; Hallquist A; Wahlberg P; Wallin G; Tibblin S
Cancer; 1994 Aug; 74(4):1348-54. PubMed ID: 8055459
[TBL] [Abstract][Full Text] [Related]
58. Survival and Surgical Complications in Anaplastic Thyroid Cancer Patients After Completed Multimodal Treatment.
Lorntzsen B; Jacobsen AB; GrØholt KK; Sigstad E; Osnes T
Anticancer Res; 2020 Dec; 40(12):6979-6985. PubMed ID: 33288592
[TBL] [Abstract][Full Text] [Related]
59. Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.
Vrbic S; Pejcic I; Vrbic M; Filipovic S
J BUON; 2009; 14(1):41-4. PubMed ID: 19373945
[TBL] [Abstract][Full Text] [Related]
60. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
